Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy
- Andrea Aiello*
- , Anna D'Ausilio
- , Roberta Lo Muto
- , Francesca Randon
- , Luca Laurenti
*Corresponding author
- Creativ–Ceutical
- Janssen-Cilag SpA
Research output: Contribution to journal › Article